Evaluation of Preexisting Immunity Markers in Human Tumor Tissue Sample
3 other identifiers
observational
300
1 country
1
Brief Summary
The purpose of this study is to evaluate markers of immune response in human tumor samples.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Sep 2006
Typical duration for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
September 1, 2006
CompletedFirst Submitted
Initial submission to the registry
December 4, 2007
CompletedFirst Posted
Study publicly available on registry
December 6, 2007
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2008
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2008
CompletedApril 11, 2011
April 1, 2011
2.3 years
December 4, 2007
April 7, 2011
Conditions
Eligibility Criteria
Any adult patient with a tumor who is scheduled to undergo surgery to either remove or biopsy the tumor.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Stanford University School of Medicine
Stanford, California, 94305, United States
Biospecimen
tumor tissue sample
MeSH Terms
Conditions
Study Officials
- PRINCIPAL INVESTIGATOR
Jeffrey A. Norton
Stanford University
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
Study Record Dates
First Submitted
December 4, 2007
First Posted
December 6, 2007
Study Start
September 1, 2006
Primary Completion
December 1, 2008
Study Completion
December 1, 2008
Last Updated
April 11, 2011
Record last verified: 2011-04